Table 1.
Common Histone-Modifying Enzymes Amplified/Overexpressed/Mutated in Cancer
Gene | Cancer type | Alteration | References |
---|---|---|---|
EZH2 | Prostate, breast, bladder, ovarian, lung, liver, brain, kidney, gastric, esophageal, and pancreatic cancer and melanoma | Amplified/overexpressed | 36 |
MLL4 | Breast | Amplification | 37 |
SETDB1 | Melanoma, lung, prostate | Overexpressed/amplification | 35, 38, 39 |
EHMT1 | Esophageal | Overexpressed | 40 |
EHMT2 | Bladder, breast, cervical, lung, and others | Overexpressed | 41 |
KDM1A | Prostate, bladder | Overexpression | 42 |
KDM6A | Acute myelogenous leukemia, bladder | Down-regulation | 17 |
PCAF | Epithelial | Missense mutation | 43 |
P300 | Gastric, colon, breast | Biallelic and stop codon mutations | 44 |
HDAC1 | Gastric, prostate | Overexpression | 45, 46 |
AURKB | Colorectal | Overexpression | 47 |
BUB1 | Gastric | Overexpression | 48 |
RING2 and UBCH6 | Role in cancer yet to be confirmed | 49 |